Novo Holdings
Corporate VC
Novo Holdings is the controlling shareholder of Novo Nordisk and Novonesis with DKK 1,060 billion in assets under management. Invests in life science companies at all stages plus broad portfolio of equities, bonds, real estate, and private equity.
Growth
Early Stage
Pre-Seed
Seed
Life Sciences
Healthcare
biotechnology
life sciences
- Headquarters
- Copenhagen, Denmark
- Founded
- 1999
- Website
- novoholdings.dk
- AUM
- $93.0B
- Last Investment
- Jul 2025
- Geographic Focus
- North America, Europe, Asia, Denmark, Global
Investment Thesis
Invests in life science companies at all stages to improve people’s health and planetary sustainability, alongside diversified equities, bonds, real estate, and private equity.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account